Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3111091rdf:typepubmed:Citationlld:pubmed
pubmed-article:3111091lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:3111091lifeskim:mentionsumls-concept:C0034760lld:lifeskim
pubmed-article:3111091lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:3111091pubmed:issue1-2lld:pubmed
pubmed-article:3111091pubmed:dateCreated1987-7-29lld:pubmed
pubmed-article:3111091pubmed:abstractTextThe production by the hybridoma technique of a monoclonal antibody which behaves as an anti-e agglutinin is described. A reagent was made from ascitic fluid diluted in RPMI 1640 culture medium and bovine serum albumin. All red blood cells bearing the e antigen were agglutinated; no reactivity was recorded with untreated EE red cells suspensions. However, cross-reactivity was observed with enzyme-pretreated EE cells. The characteristics of this monoclonal antibody are described and are in accordance with the standard references.lld:pubmed
pubmed-article:3111091pubmed:languageenglld:pubmed
pubmed-article:3111091pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3111091pubmed:citationSubsetIMlld:pubmed
pubmed-article:3111091pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3111091pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3111091pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3111091pubmed:statusMEDLINElld:pubmed
pubmed-article:3111091pubmed:issn0042-9007lld:pubmed
pubmed-article:3111091pubmed:authorpubmed-author:GenetetBBlld:pubmed
pubmed-article:3111091pubmed:authorpubmed-author:GenetetNNlld:pubmed
pubmed-article:3111091pubmed:authorpubmed-author:BourelDDlld:pubmed
pubmed-article:3111091pubmed:authorpubmed-author:LecointreMMlld:pubmed
pubmed-article:3111091pubmed:authorpubmed-author:Gueguen-Duche...lld:pubmed
pubmed-article:3111091pubmed:issnTypePrintlld:pubmed
pubmed-article:3111091pubmed:volume52lld:pubmed
pubmed-article:3111091pubmed:ownerNLMlld:pubmed
pubmed-article:3111091pubmed:authorsCompleteYlld:pubmed
pubmed-article:3111091pubmed:pagination85-8lld:pubmed
pubmed-article:3111091pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:3111091pubmed:meshHeadingpubmed-meshheading:3111091-...lld:pubmed
pubmed-article:3111091pubmed:meshHeadingpubmed-meshheading:3111091-...lld:pubmed
pubmed-article:3111091pubmed:meshHeadingpubmed-meshheading:3111091-...lld:pubmed
pubmed-article:3111091pubmed:meshHeadingpubmed-meshheading:3111091-...lld:pubmed
pubmed-article:3111091pubmed:meshHeadingpubmed-meshheading:3111091-...lld:pubmed
pubmed-article:3111091pubmed:meshHeadingpubmed-meshheading:3111091-...lld:pubmed
pubmed-article:3111091pubmed:meshHeadingpubmed-meshheading:3111091-...lld:pubmed
pubmed-article:3111091pubmed:meshHeadingpubmed-meshheading:3111091-...lld:pubmed
pubmed-article:3111091pubmed:year1987lld:pubmed
pubmed-article:3111091pubmed:articleTitleMurine monoclonal antibody suitable for use as an Rh reagent, anti-e.lld:pubmed
pubmed-article:3111091pubmed:publicationTypeJournal Articlelld:pubmed